Valued at a market cap of $29.6 billion, San Diego, California-based DexCom, Inc. (DXCM) is a medical device company ...

The agency approved the first CGM for over-the-counter use in March. Stelo, by Dexcom, was approved for anyone 18 and older ...

With an increasing burden of diabetes in Singapore, digital innovations, research can help diabetics manage better. Read more ...

Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.

24 analysts are following DexCom and have set target prices ranging from $75.0 to $120.0 per share. On average, they have ...

We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we are going to take a look at ...

Dexcom has rounded up its celebrity spokespeople for World Diabetes Day, putting singer Nick Jonas at the center of a ...

With more than 5 million Canadians affected by diabetes, National Diabetes Awareness Month is a timely reminder of the ongoing battle against this disease. Dr. Jeremy Gilbert joins us to discuss the ...

EXCLUSIVE The singer-songwriter and actor has crammed a lot into his 32 years of life and the ‘incredibly ambitious and ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...